| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 45 | - | - | 4.617 | 6.198 | 9.690 | 27.066 | 38.685 | 35.903 |
| Total Income - EUR | - | 1.447 | - | - | 5.803 | 6.204 | 10.076 | 27.404 | 39.005 | 37.943 |
| Total Expenses - EUR | - | 3.761 | - | - | 4.485 | 3.971 | 9.813 | 19.491 | 38.661 | 31.403 |
| Gross Profit/Loss - EUR | - | -2.313 | - | - | 1.318 | 2.232 | 263 | 7.913 | 344 | 6.540 |
| Net Profit/Loss - EUR | - | -2.315 | - | - | 1.179 | 2.059 | 88 | 7.416 | 152 | 6.190 |
| Employees | - | 0 | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Bio Impact Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | - | - | 5.936 | 4.290 | 3.296 | 2.404 | 24.523 | 22.868 |
| Current Assets | - | -1.485 | - | - | 5.313 | 6.882 | 9.425 | 18.829 | 13.302 | 16.901 |
| Inventories | - | 2.159 | - | - | 3.303 | 4.758 | 5.739 | 3.258 | 5.275 | 0 |
| Receivables | - | -3.847 | - | - | 908 | 1.390 | 1.225 | 3.652 | 544 | 2.831 |
| Cash | - | 202 | - | - | 1.102 | 735 | 2.460 | 11.918 | 7.483 | 14.070 |
| Shareholders Funds | - | -2.270 | - | - | -3.429 | -1.918 | -1.787 | 5.623 | 5.759 | 11.916 |
| Social Capital | - | 45 | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 785 | - | - | 14.678 | 13.091 | 14.508 | 15.609 | 32.110 | 27.868 |
| Income in Advance | - | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Bio Impact Srl